Morgan Stanley’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.1M Buy
435,506
+135,974
+45% +$11.1M ﹤0.01% 2511
2026
Q1
$16.9M Buy
299,532
+153,418
+105% +$7.73M ﹤0.01% 3111
2025
Q4
$6.29M Buy
146,114
+116,764
+398% +$4.62M ﹤0.01% 4002
2025
Q3
$904K Buy
+29,350
New +$924K ﹤0.01% 5223

Other funds holding LGN

Morgan Stanley's LGN Position: Q2 2026 in Review

Morgan Stanley increased its Legence Corp (LGN) stake by 45% in Q2 2026, buying an estimated $11.1M and bringing the position to 435,506 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Morgan Stanley first reported a position in LGN in Q3 2025 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

  • Morgan Stanley held 435,506 shares of Legence Corp worth $37.1M as of Q2 2026.
  • Morgan Stanley bought 135,974 Legence Corp shares in Q2 2026, an estimated $11.1M.
  • Legence Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2511 holding.
  • Morgan Stanley first reported a position in Legence Corp in Q3 2025 and has held it in 4 quarters since.
  • 267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.